• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫缺陷诊断与管理的实践参数。美国过敏、哮喘与免疫学会临床与实验室免疫学委员会(CLIC - AAAAAI)。

Practice parameters for the diagnosis and management of immunodeficiency. The Clinical and Laboratory Immunology Committee of the American Academy of Allergy, Asthma, and Immunology (CLIC-AAAAI).

作者信息

Shearer W T, Buckley R H, Engler R J, Finn A F, Fleisher T A, Freeman T M, Herrod H G, Levinson A I, Lopez M, Rich R R, Rosenfeld S I, Rosenwasser L J

出版信息

Ann Allergy Asthma Immunol. 1996 Mar;76(3):282-94. doi: 10.1016/s1081-1206(10)63442-4.

DOI:10.1016/s1081-1206(10)63442-4
PMID:8634885
Abstract

In this brief review, only the most useful immunologic tests available for defining host defects that lead to susceptibility to infection have been emphasized. It should be pointed out that those evaluations and tests ordered by the physician will rule out the vast majority of the currently recognized defects. Finally, it is important that any patients identified as abnormal by these screening tests be characterized as fully as possible in centers specializing in these diseases before therapy is initiated, since what may appear to be a simple diagnosis on the surface may be an indicator of more complex underlying problems.

摘要

在这篇简短的综述中,仅着重介绍了用于确定导致易感性感染的宿主缺陷的最有用的免疫学检测。应当指出的是,医生所安排的那些评估和检测将排除绝大多数目前已认识到的缺陷。最后,重要的是,在开始治疗之前,任何经这些筛查检测确定为异常的患者都应在专门治疗这些疾病的中心尽可能全面地进行特征描述,因为表面上看似简单的诊断可能是更复杂潜在问题的一个指标。

相似文献

1
Practice parameters for the diagnosis and management of immunodeficiency. The Clinical and Laboratory Immunology Committee of the American Academy of Allergy, Asthma, and Immunology (CLIC-AAAAI).免疫缺陷诊断与管理的实践参数。美国过敏、哮喘与免疫学会临床与实验室免疫学委员会(CLIC - AAAAAI)。
Ann Allergy Asthma Immunol. 1996 Mar;76(3):282-94. doi: 10.1016/s1081-1206(10)63442-4.
2
Immunodeficiency diseases.免疫缺陷疾病。
Prog Clin Pathol. 1981;8:205-38.
3
Practice parameter for the diagnosis and management of primary immunodeficiency.原发性免疫缺陷病的诊断和管理实践参数。
J Allergy Clin Immunol. 2015 Nov;136(5):1186-205.e1-78. doi: 10.1016/j.jaci.2015.04.049. Epub 2015 Sep 12.
4
Clinical signs of immunodeficiency.免疫缺陷的临床体征。
Curr Probl Dermatol. 1989;18:42-9. doi: 10.1159/000416837.
5
Primary immunodeficiency diseases.原发性免疫缺陷病
JAMA. 1997 Dec 10;278(22):1835-41.
6
Practice parameter for the diagnosis and management of primary immunodeficiency.原发性免疫缺陷诊断与管理的实践参数
Ann Allergy Asthma Immunol. 2005 May;94(5 Suppl 1):S1-63. doi: 10.1016/s1081-1206(10)61142-8.
7
Primary immunodeficiency diseases. Scientific Group on Immunodeficiency, WHO.原发性免疫缺陷病。世界卫生组织免疫缺陷科学小组。
Birth Defects Orig Artic Ser. 1983;19(3):345-60.
8
24. Clinical and laboratory assessment of immunity.24. 免疫的临床与实验室评估。
J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S702-11. doi: 10.1067/mai.2003.122.
9
Primary immunodeficiency diseases. Report of a WHO sponsored meeting.原发性免疫缺陷病。世界卫生组织主办会议报告。
Immunodefic Rev. 1989;1(2):173-205.
10
[Diagnosis and differentiated treatment of secondary immunodeficiencies].[继发性免疫缺陷的诊断与鉴别诊断]
Ter Arkh. 2001;73(4):55-9.

引用本文的文献

1
Requirements for physician competencies in allergy: key clinical competencies appropriate for the care of patients with allergic or immunologic diseases: a position statement of the world allergy organization.过敏领域医师能力要求:适用于过敏性或免疫性疾病患者护理的关键临床能力:世界过敏组织立场声明
World Allergy Organ J. 2008 Feb;1(2):42-6. doi: 10.1097/WOX.0b013e3181651689.
2
Practice parameters in pediatric allergy.儿科过敏的实践参数
Curr Allergy Asthma Rep. 2003 Nov;3(6):473-7. doi: 10.1007/s11882-003-0057-y.
3
Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults.
健康儿童和成人中破伤风类毒素、b型流感嗜血杆菌和肺炎球菌荚膜多糖特异性抗体的水平。
Clin Diagn Lab Immunol. 2003 Mar;10(2):202-7. doi: 10.1128/cdli.10.2.202-207.2003.